UC San Diego HTC is Recruiting for a Physician
The UC San Diego Hemophilia and Thrombosis Treatment Center is actively recruiting for a hematologist experienced in the care of adult patients with hemophilia and other bleeding disorders.
We are a large, federally-funded hemophilia and thrombosis treatment center with a thriving 340B program. The HTC is staffed by an excellent and experienced multi-disciplinary team dedicated to the care of patients with bleeding and thrombotic disorders.
The successful candidate will have an academic appointment within the Division of Hematology/Oncology and be expected to participate in all aspects of academic life at UCSD, including clinical, translational or basic research (depending on the background of the successful candidate), and the education of Hematology/Oncology Fellows, Medicine Residents and medical students.
The HTC maintains excellent working relationships with hepatology, liver transplant, infectious disease, and other specialties. For more information on how to apply, click here.
UC San Diego HTC Musculoskeletal Ultrasound Research Published in Haemophilia
Dr. von Drygalski and colleagues are published in Haemophilia,
the Official Journal of the World Federation of Hemophilia for their research on the use of ultrasound in hemophilia. Click on the link to read about their research: Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation, and soft tissue abnormalities in adult patients with painful haemophilic arthropathy
UC San Diego HTC Featured in Nature
Dr. von Drygalski and the team are featured in an editorial in the prestigious scientific publication Nature for their efforts to further the field of musculoskeletal ultrasound. This editorial highlights Dr. von Drygalski's research showing that a significant amount of painful episodes associated with bleeding into the joint are misdiagnosed. Oftentimes, these painful episodes are associated with normal arthritic pain vs.joint bleeding. Dr. von Drygalski is able to distinguish between inflammation and bleeding into the joint through the use of musculoskeletal ultrasound, an imaging technique that is less costly than magnetic resonance imaging (MRI) and provides greater detail into the overall health of the joint.
Read the editorial.
"Top Doc" at the UC San Diego HTC
Dr. Annette von Drygalski, Director of the UC San Diego Hemophilia and Thrombosis Treatment Center, was honored as one of San Diego’s 2014 “Top Docs” by San Diego Magazine and the San Diego County Medical Society.
The distinction is made every year following a selective survey and voting process by San Diego board-certified physicians to nominate expert physicians who excel in their field. A celebratory evening gala was held at the Birch Aquarium on November 1st in recognition of everyone named “Physicians of Exceptional Excellence” this year. The event overlooked the setting sun and guests were treated to a cool ocean breeze. Dr. von Drygalski and the team celebrated their achievements next to the aquarium’s exhibits of the underwater world.
The UC San Diego HTC is one of few centers in the United States offering specialized care for patients living with bleeding disorders such as hemophilia and von Willebrand disease. The UC San Diego HTC provides individualized services for a comprehensive patient experience including, but not limited to: emergency care, routine diagnosis and management, social work services, physical therapy, and rapid bleed detection through ultrasound technology. In the future, the center is looking to expand services to young adults with bleeding disorders to facilitate the transition of care from adolescence to adulthood.
The physicians and staff at the UC San Diego HTC are dedicated to provide new approaches to improve overall patient health outcomes. The center provides opportunities for patients to participate in cutting-edge clinical research studies to advance new therapies and create innovative knowledge on the developing needs of the aging hemophilia population. In addition, the UC San Diego HTC is launching new interactive programs geared at improving patient health, including the new Rock Climbing Program. The center’s new climbing program is focused on therapeutic measures to improve joint health.
UC San Diego HTC Climbing Rocks!
Harness. Grip. Lift. Balance. Climb. Every week at the Solid Rock Gym in Old Town, the UCSD Hemophilia & Thrombosis Treatment Center (HTC) hosts a rock climbing session for patients with hemophilia. The new therapeutic rock climbing program, now it its third month, offered a fun interactive activity aimed at providing joint therapy for patients with hemophilia.
Gabe, a climbing participant, attempts to master a tough wall!
Partnering with the Hemophilia Association of San Diego County and the University of Munich, the UCSD HTC’s rock climbing program strives to increase range of motion, decrease frequency of bleeds, improve communication skills, foster team building and increase overall quality of life for patients.
Gabe, a frequent participant, knew from previous experience that rock climbing was not an easy activity but has since learned all the benefits the activity has for joint health. “It’s a lot of fun, and it’s something I look forward to every week” he says.
Generally, the only options for physical activities recommended for hemophilia patients are swimming and golfing. These restrictions often make it difficult for patients looking for alternative options for physical exercise.
“[The program] is amazing,” says Albert, another climbing participant, “I didn’t know rock climbing was so fun!”
Both Albert and Gabe hope future hemophilia programs will feature more interactive activities like rock climbing and other activities that kids can also get involved in.
The challenge of the rock wall is only the beginning. Through climbing, participants build strength, flexibility and endurance. In addition, in order to successfully finish a climb, climbers need to exercise trust in both the mind and the body with each step.
“Just keep climbing to the top,” says Gabe.